Literature DB >> 25088614

Association of GABRA6 1519 T>C (rs3219151) and Synapsin II (rs37733634) gene polymorphisms with the development of idiopathic generalized epilepsy.

D K V Prasad1, Uzma Shaheen1, U Satyanarayana2, T Surya Prabha3, A Jyothy4, Anjana Munshi5.   

Abstract

The idiopathic generalized epilepsy (IGE) is a neurological disorder which accounts for approximately 30% of all epilepsy cases. Patients identified with IGE syndromes have pharmacoresponsive epilepsies without abnormal neurological symptoms, structural brain lesions and are of unknown origin. A genetic etiology to IGEs has been proposed. Gamma amino butyric acid (GABA), a major inhibitory neurotransmitter acts by binding to transmembrane GABAA and GABAB receptors of both pre- and postsynaptic neurons. Synapsin II (SynII), a neuron specific phosphoprotein plays a major role in synaptogenesis and neurotransmitter release. The present study was carried out with an aim to evaluate the association of GABRA6 (rs3219151) T>C and Syn II (rs37733634) A>G gene polymorphisms with IGE. Molecular analysis revealed that the frequency of 'CC' genotype and 'C'allele of GABRA6 (rs3219151) T>C gene polymorphism was significantly higher in IGE patients compared to healthy controls [CC vs. TT, χ2=26; p<0.001; Odds ratio=3.6 (95% CI; 2.1-5.9); C vs T, χ2=24.7; p<0.001; Odds ratio=1.78 (95% CI; 1.4-2.2)]. The frequency of 'GG' genotype and 'G' allele of the intronic polymorphism A>G in Syn II gene was also found to be significantly associated with the disease when compared to controls [GG vs AA, χ2=64.52; p<0.001; Odds ratio=7.37 (95% CI; 4.4-12.3); G vs. A, χ2=65.78; p<0.001; Odds ratio=2.57 (95% CI; 2.0-3.2)]. The generalized multifactor dimensionality reduction method was employed to detect gene-gene interactions. The gene-gene interaction at two loci involving GABRA6 and Syn II revealed a significant association [χ2=36.6, p<0.001, Odds ratio=3.17 (95% CI; 2.2-4.6)] with IGE. Therefore, the present study clearly indicates that both GABRA6 (rs3219151) T>C and Syn II (rs37733634) A>G polymorphisms are important risk factors for the development of IGE in the South Indian population from Andhra Pradesh. The gene-gene interaction studies demonstrated significant interactive effects of these two loci in the development of the disease.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epileptogenesis; Gamma-amino butyric acid (GABA); Gene–gene interaction; Idiopathic generalized epilepsies; Neurotransmitter; Synapsin II

Mesh:

Substances:

Year:  2014        PMID: 25088614     DOI: 10.1016/j.eplepsyres.2014.07.001

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  8 in total

1.  Synapsin II Regulation of GABAergic Synaptic Transmission Is Dependent on Interneuron Subtype.

Authors:  Pedro Feliciano; Heidi Matos; Rodrigo Andrade; Maria Bykhovskaia
Journal:  J Neurosci       Date:  2017-01-13       Impact factor: 6.167

2.  Growth and excitability at synapsin II deficient hippocampal neurons.

Authors:  Heidi Matos; Raymond Quiles; Rodrigo Andrade; Maria Bykhovskaia
Journal:  Mol Cell Neurosci       Date:  2019-03-09       Impact factor: 4.314

Review 3.  The Role of Synapsins in Neurological Disorders.

Authors:  Fatima Javed Mirza; Saadia Zahid
Journal:  Neurosci Bull       Date:  2017-12-27       Impact factor: 5.203

4.  Impact of GABAA receptor gene variants (rs2279020 and rs211037) on the risk of predisposition to epilepsy: a case-control study.

Authors:  Maryam Amjad; Atiya Tabassum; Khalid Sher; Suneel Kumar; Sitwat Zehra; Sehrish Fatima
Journal:  Neurol Sci       Date:  2022-02-12       Impact factor: 3.307

5.  No association of GABRA1 rs2279020 and GABRA6 rs3219151 polymorphisms with risk of epilepsy and antiepileptic drug responsiveness in Asian and Arabic populations: Evidence from a meta-analysis with trial sequential analysis.

Authors:  Tiejun Zhang; Yi Yang; Xiutian Sima
Journal:  Front Neurol       Date:  2022-09-14       Impact factor: 4.086

Review 6.  Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment.

Authors:  Sarita Thakran; Debleena Guin; Pooja Singh; Priyanka Singh; Samiksha Kukal; Chitra Rawat; Saroj Yadav; Suman S Kushwaha; Achal K Srivastava; Yasha Hasija; Luciano Saso; Srinivasan Ramachandran; Ritushree Kukreti
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

7.  Genetic analysis of benign familial epilepsies in the first year of life in a Chinese cohort.

Authors:  Qi Zeng; Xiaoling Yang; Jing Zhang; Aijie Liu; Zhixian Yang; Xiaoyan Liu; Ye Wu; Xiru Wu; Liping Wei; Yuehua Zhang
Journal:  J Hum Genet       Date:  2017-11-13       Impact factor: 3.172

8.  Synapsin II Directly Suppresses Epileptic Seizures In Vivo.

Authors:  Ryan Schwark; Rodrigo Andrade; Maria Bykhovskaia
Journal:  Brain Sci       Date:  2022-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.